The Efficacy of Imeglimin and Metformin on Insulin Sensitivity and Secretion Using Oral Minimal Model: Sub‐Analysis of an Exploratory Randomised Controlled Trial

Documenti analoghi

• Differential effects of imeglimin and metformin on insulin and incretin secretion—An exploratory randomized controlled trial
  di: Ryota Usui, et al.
  Pubblicazione: (2024)
• Short‐term outcomes of switching from GLP ‐1 receptor agonists to tirzepatide in type 2 diabetes: A retrospective, observational study in clinical practice
  di: Mari Matsushiro, et al.
  Pubblicazione: (2025)
• BALLAST study: A multicentre, open‐label, randomized‐controlled, 52‐week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine‐enriched amino acid supplementation and physical exercise programme
  di: Yoshihiro Takahashi, et al.
  Pubblicazione: (2026)
• β‐Adrenergic Blockers Increase cAMP and Stimulate Insulin Secretion Through a PKA / RYR2 / TRPM5 Pathway in Pancreatic β‐Cells In Vitro
  di: Naoya Murao, et al.
  Pubblicazione: (2025)
• Evaluate muscle mass when setting target body weight
  di: Yuji Yamazaki, et al.
  Pubblicazione: (2025)